NCT05107219 2026-04-07
GCC Agonist Signal in the Small Intestine
University of Wisconsin, Madison
Phase 1 Completed
Clinical Trials
27 trialsNCT05984602 2026-03-30
A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer
NYU Langone Health
Phase 1 Active not recruiting
NCT07329894 2026-02-12
Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastrointestinal Cancer
Beijing GoBroad Hospital
Phase 1 Recruiting
NCT07319364 2026-01-06
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1 Recruiting
NCT06065371 2025-12-19
Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
Henry Ford Health System
Phase 1 Recruiting
NCT05220046 2025-12-17
Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers
University of Nebraska
Phase 1 Active not recruiting
NCT05274048 2025-10-29
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
Fox Chase Cancer Center
Phase 1 Recruiting
NCT06414733 2025-08-24
HER-2 B Cell Peptide Vaccine
Indiana University
Phase 1 Recruiting
NCT04145297 2024-11-18
UTAH
University of Utah
Phase 1 Completed
NCT04130763 2024-09-24
Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of Anti- PD-1
Peking University
Phase 1 Completed
NCT06012734 2024-08-30
CoLBAt
The Netherlands Cancer Institute
Phase 1 Recruiting
NCT04131426 2023-08-15
Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia
University of Rochester
Phase 1 Completed
NCT02333188 2023-05-31
Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer
University of Chicago
Phase 1 Completed
NCT01790035 2022-03-16
LGG
Washington University School of Medicine
Phase 1 Terminated
NCT01966289 2021-03-30
SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT01375699 2019-08-26
Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers
Virginia Commonwealth University
Phase 1 Completed
NCT02387138 2019-08-22
SIRINOX
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 1 Completed
NCT01639911 2019-07-22
Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors
University of Illinois at Chicago
Phase 1 Completed
NCT01843725 2018-01-31
MOMENTUM1
Jules Bordet Institute
Phase 1 Completed
NCT01200316 2017-11-30
Rocking Motion: Physiologic Effect on the Surgical Stress Response
M.D. Anderson Cancer Center
Phase 1 Completed
NCT02513849 2017-05-09
Tamoxifen in Patients With Oesophageal Cancer
University of Nottingham
Phase 1 Unknown
NCT01693445 2016-02-19
S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer
Hallym University Medical Center
Phase 1 Completed
NCT02512328 2015-07-30
PERICLESAPPI
Technical University of Munich
Phase 1 Unknown
NCT01294826 2015-06-08
Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Swedish Medical Center
Phase 1 Completed
NCT00585637 2015-04-01
Vitamin D for Chemoprevention
Dana-Farber Cancer Institute
Phase 1 Completed
NCT02169388 2014-06-25
Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy
Shandong University
Phase 1 Unknown
NCT00436657 2012-04-02
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer
M.D. Anderson Cancer Center
Phase 1 Completed